INCREASED EXPRESSION OF MUTANT FORMS OF THE P53 ONCOGENE IN PRIMARY LUNG-CANCER

被引：0
|
作者：
IGGO, R
GATTER, K
BARTEK, J
LANE, D
HARRIS, AL
机构：
[1] RES INST CLIN & EXPTL ONCOL, BRNO, CZECHOSLOVAKIA
[2] IMPERIAL CANC RES FUND, MOLEC IMMUNOCHEM LAB, S MIMMS EN6 3LD, HERTS, ENGLAND
[3] UNIV OXFORD, JOHN RADCLIFFE HOSP, DEPT PATHOL, OXFORD OX3 9DU, ENGLAND
[4] JOHN RADCLIFFE HOSP, INST MOLEC MED,IMPERIAL CANC RES FUND,ONCOL UNIT, MOLEC ONCOL LAB, OXFORD OX3 9DU, ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1990年 / 62卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：505 / 505
页数：1
相关论文
共 50 条
  • [31] The Contrived Mutant p53 Oncogene - Beyond Loss of Functions
    Sabapathy, Kanaga
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [32] PROGNOSTIC-SIGNIFICANCE OF P53 AND RAS P21 EXPRESSION IN NONSMALL CELL LUNG-CANCER
    FUJINO, M
    DOSAKAAKITA, H
    HARADA, M
    HIROUMI, H
    KINOSHITA, I
    AKIE, K
    KAWAKAMI, Y
    CANCER, 1995, 76 (12) : 2457 - 2463
  • [33] MUTATIONS IN THE P53 GENE ARE FREQUENT IN PRIMARY, RESECTED NON-SMALL-CELL LUNG-CANCER
    CHIBA, I
    TAKAHASHI, T
    NAU, MM
    DAMICO, D
    CURIEL, DT
    MITSUDOMI, T
    BUCHHAGEN, DL
    CARBONE, D
    PIANTADOSI, S
    KOGA, H
    REISSMAN, PT
    SLAMON, DJ
    HOLMES, EC
    MINNA, JD
    ONCOGENE, 1990, 5 (10) : 1603 - 1610
  • [34] Mutant p53 in colon cancer
    Nakayama, Mizuho
    Oshima, Masanobu
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (04) : 267 - 276
  • [35] Breathing new insights into the role of mutant p53 in lung cancer
    Chen, Tianwei
    Ashwood, Lauren M.
    Kondrashova, Olga
    Strasser, Andreas
    Kelly, Gemma
    Sutherland, Kate D.
    ONCOGENE, 2025, 44 (03) : 115 - 129
  • [36] Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53
    Zhou, Renyuan
    Shanas, Renee
    Nelson, Mark A.
    Bhattacharyya, Achyut
    Shi, Jiaqi
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (02) : 395 - 404
  • [37] EXPRESSION OF P53 ONCOPROTEIN IN NON-SMALL-CELL LUNG-CANCER - A FAVORABLE PROGNOSTIC FACTOR
    LEE, JS
    YOON, A
    KALAPURAKAL, SK
    RO, JY
    LEE, JJ
    TU, N
    HITTELMAN, WN
    HONG, WK
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) : 1893 - 1903
  • [38] ABNORMAL P53 EXPRESSION IN HUMAN LUNG-CANCER IS ASSOCIATED WITH HISTOLOGIC SUBTYPES AND PATIENT SMOKING HISTORY
    DOSAKAAKITA, H
    SHINDOH, M
    FUJINO, M
    KINOSHITA, I
    AKIE, K
    KATOH, M
    KAWAKAMI, Y
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (05) : 660 - 664
  • [39] p53 and lung cancer
    Brambilla, E
    Brambilla, C
    PATHOLOGIE BIOLOGIE, 1997, 45 (10): : 852 - 863
  • [40] EXPRESSION OF THE NUCLEAR ONCOGENE P53 IN COLON TUMORS
    VANDENBERG, FM
    TIGGES, AJ
    SCHIPPER, MEI
    DENHARTOGJAGER, FCA
    KROES, WGM
    WALBOOMERS, JMM
    JOURNAL OF PATHOLOGY, 1989, 157 (03): : 193 - 199
12345